• 719-347-5400
  • info@realmofcaring.org
  • 719-347-5400
  • info@realmofcaring.org
  • Home
  • Research
    • Observational Research Registry
    • Company Interest
    • Research Library
  • Resources
    • Client Portal
      • Dosing & Administration
      • Client Education Series
      • Client F.A.Q.
        • Client Additional Questions
      • For Pets
      • Glossary
      • Observational Research Registry
      • Printable Resources
      • Supported Brands
    • Healthcare Portal
      • Dosing & Administration
      • Join Our List of Healthcare Professionals
      • Practitioner Education
    • Blog
      • Blog: Client Stories
      • Blog: Education
    • Find a Provider
      • Locate a Healthcare Professional
      • MMJ Recommendations
    • Aspen Green Giveaway
  • About
    • Who We Are
    • In the News
    • Supported Brands
    • Our Supporters
    • Financials
  • Contact Us
Menu
  • Home
  • Research
    • Observational Research Registry
    • Company Interest
    • Research Library
  • Resources
    • Client Portal
      • Dosing & Administration
      • Client Education Series
      • Client F.A.Q.
        • Client Additional Questions
      • For Pets
      • Glossary
      • Observational Research Registry
      • Printable Resources
      • Supported Brands
    • Healthcare Portal
      • Dosing & Administration
      • Join Our List of Healthcare Professionals
      • Practitioner Education
    • Blog
      • Blog: Client Stories
      • Blog: Education
    • Find a Provider
      • Locate a Healthcare Professional
      • MMJ Recommendations
    • Aspen Green Giveaway
  • About
    • Who We Are
    • In the News
    • Supported Brands
    • Our Supporters
    • Financials
  • Contact Us
  • Donate
  • Register
  • Login
  • Home
  • Research
    • Observational Research Registry
    • Company Interest
    • Research Library
  • Resources
    • Client Portal
      • Dosing & Administration
      • Client Education Series
      • Client F.A.Q.
        • Client Additional Questions
      • For Pets
      • Glossary
      • Observational Research Registry
      • Printable Resources
      • Supported Brands
    • Healthcare Portal
      • Dosing & Administration
      • Join Our List of Healthcare Professionals
      • Practitioner Education
    • Blog
      • Blog: Client Stories
      • Blog: Education
    • Find a Provider
      • Locate a Healthcare Professional
      • MMJ Recommendations
    • Aspen Green Giveaway
  • About
    • Who We Are
    • In the News
    • Supported Brands
    • Our Supporters
    • Financials
  • Contact Us
Menu
  • Home
  • Research
    • Observational Research Registry
    • Company Interest
    • Research Library
  • Resources
    • Client Portal
      • Dosing & Administration
      • Client Education Series
      • Client F.A.Q.
        • Client Additional Questions
      • For Pets
      • Glossary
      • Observational Research Registry
      • Printable Resources
      • Supported Brands
    • Healthcare Portal
      • Dosing & Administration
      • Join Our List of Healthcare Professionals
      • Practitioner Education
    • Blog
      • Blog: Client Stories
      • Blog: Education
    • Find a Provider
      • Locate a Healthcare Professional
      • MMJ Recommendations
    • Aspen Green Giveaway
  • About
    • Who We Are
    • In the News
    • Supported Brands
    • Our Supporters
    • Financials
  • Contact Us
  • Donate
  • Login

Research Library

A-Z Conditions  Participate in ORR

Cannabinoids as potential new therapy for the treatment of gliomas

  • Journal : Expert Reviews Neurotherapeutics
  • Publication Year : 2008
  • Authors : Daniela Parolaro; Paola Massi

Gliomas constitute the most frequent and malignant primary brain tumors. Current standard
therapeutic strategies (surgery, radiotherapy and chemotherapeutics, e.g., temozolomide,
carmustin or carboplatin) for their treatment are only palliative and survival diagnosis is
normally 6–12 months. The development of new therapeutic strategies for the management
of gliomas is therefore essential. Interestingly, cannabinoids have been shown to exert
antiproliferative effects on a wide spectrum of cells in culture. Of interest, cannabinoids have
displayed a great potency in reducing glioma tumor growth either in vitro or in animal
experimental models, curbing the growth of xenografts generated by subcutaneous or
intratecal injection of glioma cells in immune-deficient mice. Moreover, cannabinoids appear
to be selective antitumoral agents as they kill glioma cells without affecting the viability of
nontransformed counterparts. A pilot clinical trial on patients with glioblastoma multiforme
demonstrated their good safety profile together and remarkable antitumor effects, and may
set the basis for further studies aimed at better evaluating the potential anticancer activity of
cannabinoids.

Read the Full Article

Share This:

Share on Twitter Share on Facebook Share on LinkedIn Share on Email
NextCannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptorsNext

Conditions:

  • Glioma

Research Information:

Research Keywords:

  • angiogenesis, apoptosis, cannabidoid, clinical trial, endocannabinoid system, giloma, tumor growth

Search the Research Library >

Follow Us:

Facebook Twitter Youtube

REGISTER WITH THE RoC TODAY!

Realm of Caring focuses on research, education, building community, and improving quality of life. We are an educational resource for consumers, physicians, scientists, governments and the media.
Register now
  • 5040 Corporate Plaza Drive, Suite 7R, Colorado Springs, CO 80919
  • 719-347-5400
  • info@realmofcaring.org

Copyright © 2021 / Realm of Caring Foundation, Inc

  • Privacy
  • Disclaimer